Articles

Novel Pharmacologic Treatments for Cardiovascular Disease: A Practical Update

Citation:

US Cardiology Review 2017;11(2):98–104.

Left Ventricular Assisting Devices in Percutaneous Coronary Intervention

Citation:

US Cardiology Review 2017;11(2):86–94.

Advances in Coronary Physiology: Update for 2017

Citation:

US Cardiology Review 2017;11(2):80–5.

The Impact of an Atrial Septal Defect on Hemodynamics in Patients With Heart Failure

Citation:

US Cardiology Review 2017;11(2):72–4.

Clinical Trial Perspective: Optimizing Crossover From Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome (CAPITAL OPTICROSS)

Citation:

US Cardiology Review 2017;11(2):59–61.

Controversies in Antiplatelet and Anticoagulation Therapy in Patients Presenting with Acute Coronary Syndrome

Citation:

US Cardiology Review 2017;11(2):52–8.

Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?

Citation:

US Cardiology Review 2017; 11(1):37–8

Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial

Citation:

US Cardiology Review 2017;11(1):18–9

Foreword

Citation:

US Cardiology Review 2017;11(1):4

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Citation:

US Cardiology Review 2017;11(1):16–7